Publication | Open Access
Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma
46
Citations
24
References
2003
Year
GC administered according to a 3-week schedule was a highly active and safe regimen in patients with primary, unresectable, locally advanced NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1